This study found that exosomes from mesenchymal stromal cells can enhance the effects of imatinib — a chemotherapy drug — in killing human leukemia cells. The exosomes worked by activating the caspase signaling pathway involved in programmed cell death.

This research suggests a promising adjunct role for exosomes in cancer therapy, particularly in blood cancers like leukemia.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.